December 9, 2021

Seer named to the 2021 CB Insights Digital Health 150

CB Insights today named Seer to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. Seer was recognised for its achievements in the ranking’s Screening, Monitoring & Diagnostics category.

The 2021 Digital Health 150 cohort includes startups at various investment stages of development, from early-stage to well-funded unicorns. The 2021 Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event, and includes startups working on data integration & analytics, hybrid virtual / in-person care, digital therapeutics, clinical intelligence, and more.

The CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies globally. The companies were assessed based on business models, demonstrated momentum in the market, data submitted by the companies, and Mosaic scores – CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.

Featured in the Screening, Monitoring and Diagnostics category, this marks the debut of Seer in the globally recognised pool of digital health leaders.

“Seer was founded to empower people to take greater control of their health by making clinical-grade monitoring more accessible. It is exciting to be named amongst other leading companies this year, many of which are equally committed to transforming healthcare delivery and improving patient outcomes,” said Seer CEO & co-founder Dr Dean Freestone.

Seer was the only Australian company to be named in the list in 2021, alongside companies from 17 other nations.

“Seer is Australia’s largest provider of epilepsy monitoring services, and we look forward to expanding our reach to make home-based gold-standard monitoring available globally in 2022,” Dr Freestone added. “The technological foundation we have built across Seer’s patented wearables, mobile app, cloud and machine learning technologies will enable us to scale rapidly while improving the experience of long-term monitoring for patients.”

“This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging,” said Brian Lee, SVP of CB Insights’ Intelligence Unit.

“Last year’s class has seen more than 20 exits, raised an additional $18.6B in aggregate funding, and announced over 250 partnerships since being recognized, and we’re excited to see the future success of this year’s winners.”